Kern K A, Rosenberg R J
Department of Surgery, Hartford Hospital, and the University of Connecticut School of Medicine, USA.
J Am Coll Surg. 2000 Nov;191(5):479-89. doi: 10.1016/s1072-7515(00)00720-1.
Preoperative lymphoscintigraphy has been recommended to confirm the successful uptake and direction of migration of radiotracer into sentinel nodes during lymphatic mapping for breast cancer. In addition, preoperative lymphatic mapping may provide a visually useful aid to the relative location of sentinel nodes within a nodal basin. One common method of breast lymphoscintigraphy involves injections of unfiltered technetium 99m sulfur colloid (Tc-99m-SC) directly into parenchymal tissues surrounding a tumor or biopsy cavity (IP injection). Because of the many imaging failures and prolonged imaging times of IP lymphoscintigraphy, the procedure has fallen into disfavor by oncologic surgeons. The purpose of this study is to document the increased success rate of preoperative breast lymphoscintigraphy using a new anatomic site of injection, the subareolar lymphatic plexus (SA injection).
In the 12 months between December 1, 1998, and December 29, 1999, 42 women with stage I and II breast cancer underwent preoperative lymphoscintigraphy by either the IP (n = 12, December 1998 to May 1999) or SA (n = 30, May 1999 to December 1999) route of injection. Both groups were injected with 1 mCi (37 MBq) of unfiltered Tc-99m-SC followed immediately by external gamma-camera imaging. The success rate for preoperative sentinel node imaging and the total imaging time were recorded in both groups.
The success rate of identifying a sentinel node by SA lymphoscintigraphy was 90% (n = 27 of 30 patients), compared with 50% (n = 6 of 12 patients) for IP lymphoscintigraphy (p = 0.009). The imaging time in the SA injection group was 34 +/- 16 minutes, which was 59% shorter than the imaging time in the IP injection group of 82 +/- 48 minutes (p < 0.001). No uptake into internal mammary nodes was seen in either group.
Moving the site of injection ofunfiltered Tc-99m-SC to the subareolar lymphatic plexus (SA injection) increased the success rate of preoperative lymphoscintigraphy to 90%, compared with 50% using IP injections. Preoperative SA lymphoscintigraphy resulted in the rapid visualization of axillary sentinel nodes within 30 minutes of SA injection, enabling a visual determination of the approximate number of sentinel nodes and their relative locations within the axilla. We conclude SA injection of unfiltered Tc-99m-SC is superior to IP injections when performing preoperative breast lymphoscintigraphy and is a visually useful aid to lymphatic mapping for breast cancer.
术前淋巴闪烁造影已被推荐用于在乳腺癌淋巴图谱绘制过程中,确认放射性示踪剂成功摄取并向前哨淋巴结迁移的情况及方向。此外,术前淋巴图谱绘制可为前哨淋巴结在淋巴结区域内的相对位置提供直观有用的辅助信息。乳腺淋巴闪烁造影的一种常见方法是将未过滤的锝99m硫胶体(Tc-99m-SC)直接注射到肿瘤或活检腔周围的实质组织中(即瘤周注射)。由于瘤周淋巴闪烁造影存在诸多成像失败情况且成像时间延长,该方法已不受肿瘤外科医生青睐。本研究的目的是记录采用新的注射解剖部位——乳晕下淋巴丛(乳晕下注射)进行术前乳腺淋巴闪烁造影时成功率的提高情况。
在1998年12月1日至1999年12月29日的12个月间,42例I期和II期乳腺癌女性患者通过瘤周注射(n = 12,1998年12月至1999年5月)或乳晕下注射(n = 30,1999年5月至1999年12月)途径接受术前淋巴闪烁造影。两组均注射1毫居里(37兆贝可)未过滤的Tc-99m-SC,随后立即进行体外γ相机成像。记录两组术前前哨淋巴结成像的成功率及总成像时间。
乳晕下淋巴闪烁造影识别前哨淋巴结的成功率为90%(30例患者中的27例),而瘤周淋巴闪烁造影的成功率为50%(12例患者中的6例)(p = 0.009)。乳晕下注射组的成像时间为34±16分钟,比瘤周注射组的82±48分钟短59%(p < 0.001)。两组均未发现内乳淋巴结有摄取情况。
将未过滤的Tc-99m-SC的注射部位移至乳晕下淋巴丛(乳晕下注射),使术前淋巴闪烁造影的成功率提高至90%,而瘤周注射的成功率为50%。术前乳晕下淋巴闪烁造影在乳晕下注射后30分钟内即可快速显示腋窝前哨淋巴结,能够直观确定前哨淋巴结的大致数量及其在腋窝内的相对位置。我们得出结论,在进行术前乳腺淋巴闪烁造影时,未过滤的Tc-99m-SC乳晕下注射优于瘤周注射,且对乳腺癌淋巴图谱绘制具有直观有用的辅助作用。